Confo Therapeutics secured a EUR 1.6 million VLAIO grant to expand R&D efforts in next-generation medicines targeting Class B GPCRs for endocrine and metabolic diseases.
Round Type
Seed
GhentBiotechnologyInvestors
Description
Confo Therapeutics has been awarded a EUR 1.6 million grant from Flanders Innovation & Entrepreneurship (VLAIO) to expand its ongoing R&D efforts in the discovery of next-generation medicines targeting Class B GPCRs using its patent-protected technology platform. The 2-year grant will be used to strengthen the company's small molecule and antibody discovery efforts on high-value Class B GPCRs, particularly in chronic endocrine and metabolic diseases such as obesity.
Quick answer
Confo Therapeutics raised an undisclosed amount in a Seed round, dated March 28, 2024. Investors: Flanders Innovation & Entrepreneurship (Vlaio). Confo Therapeutics is based in Ghent, East Flanders, Belgium.
- How much did Confo Therapeutics raise?
- Confo Therapeutics raised an undisclosed amount in a Seed round on March 28, 2024.
- Who invested in Confo Therapeutics?
- Flanders Innovation & Entrepreneurship (Vlaio) is named as investors in this round.
- What does Confo Therapeutics do?
- Confo Therapeutics is the only GPCR company with a proprietary discovery engine that precisely targets desired GPCR conformations.
- Where is Confo Therapeutics based and how big is it?
- Confo Therapeutics is based in Ghent, East Flanders, Belgium. Fundz records about 51 employees.
- Who are the decision-makers at Confo Therapeutics?
- Fundz holds 1 contact at Confo Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Confo Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Gemini BioProducts raised $5.7M (Seed) on May 10, 2024.
- BioVaxys Technology Corp. raised $52K on May 10, 2024.
- Resolute Science raised $250K on May 10, 2024.
- Commit Biologics raised $17M (Seed) on May 10, 2024.
- Aurita raised $180K (Seed) on May 10, 2024.
- Aardvark Therapeutics raised $85M (Series C) on May 9, 2024.
Who to call at Confo Therapeutics, and when
A new round usually means Confo Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Confo Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Confo Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Confo Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Confo Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Confo Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.